Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Doctor Survey Results Will Inform FDA Policy On Risk Communication

This article was originally published in The Tan Sheet

Executive Summary

Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate about the value of communicating early risk signals

You may also be interested in...



FDA Risk Communication Committee Recommends Clarity, Predictability

FDA's Risk Communication Advisory Committee submitted six broad recommendations Nov. 12 with an emphasis on making product risk announcements more predictable and available more quickly

FDA Risk Communication Committee Recommends Clarity, Predictability

FDA's Risk Communication Advisory Committee submitted six broad recommendations Nov. 12 with an emphasis on making product risk announcements more predictable and available more quickly

FDA Risk Communication Committee Recommends Clarity, Predictability

FDA's Risk Communication Advisory Committee submitted six broad recommendations Nov. 12 with an emphasis on making product risk announcements more predictable and available more quickly

Topics

UsernamePublicRestriction

Register

PS102911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel